ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

Sanding Study Section For Cancer Control Grants Needed, Board Says

May 17, 1985

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

Farber Grant Probe Misses Real Story

July 8, 1977